Introduction
Siberian ginseng (Eleutherococcus senticosus) is an adaptogenic herb traditionally used in Russian and Chinese medicine to support stamina and resilience to stress. While its general safety profile in healthy adults is well documented, the evidence base for use during pregnancy, lactation and in paediatric populations remains sparse. In this article we review the available literature, highlight the gaps, and explain why we err on the side of caution. Our approach is grounded in the principle that vulnerable populations require a higher threshold of safety evidence before recommending any botanical intervention.
Pregnancy Safety Evidence
The use of Siberian ginseng during pregnancy is not well studied. A 2003 review by Huntley et al. in Drug Safety examined herbal medicine use in pregnancy and noted that adaptogens like Siberian ginseng lack robust safety data (Huntley et al., 2003, PMID 12602629). The authors concluded that until more evidence is available, caution is warranted. A more recent systematic review by Dante et al. (2014) in Journal of Maternal-Fetal & Neonatal Medicine similarly found no adequate studies on Siberian ginseng in pregnant women (Dante et al., 2014, PMID 23327299). Animal studies are limited: one rat study reported no teratogenic effects at moderate doses, but the relevance to humans is uncertain. Traditional use in Russia includes references to avoiding the herb during pregnancy, as noted in the Complete German Commission E Monographs (1998), which state that Siberian ginseng is contraindicated during pregnancy due to lack of safety data. In our reading, the precautionary principle applies: without human trials demonstrating safety, we cannot recommend Siberian ginseng for pregnant women.
Lactation Considerations
Data on Siberian ginseng excretion into breast milk are absent. No pharmacokinetic studies have measured eleutherosides or other active constituents in human milk. The German Commission E monograph also advises against use during lactation. A 2016 review in Breastfeeding Medicine by Budzynska et al. (PMID 27314160) evaluated herbal medicine safety in breastfeeding and listed Siberian ginseng as having “insufficient safety data,” recommending avoidance. The theoretical concern is that adaptogenic compounds may affect the infant’s developing stress-response system or cause unknown adverse effects. In our experience, the lack of evidence is not evidence of safety. We advise lactating women to avoid Siberian ginseng until more research is conducted.
Paediatric Dosing If Any
There is no established paediatric dosing for Siberian ginseng. Clinical trials in children are virtually nonexistent. A 2010 review by Gardiner et al. in Pediatrics (PMID 20624866) on herbal medicine use in children noted that Siberian ginseng is sometimes used for “stress” or “immune support,” but the authors found no high-quality evidence to support efficacy or safety in paediatric populations. The European Medicines Agency (EMA) monograph on Eleutherococcus senticosus does not include paediatric indications. Traditional use in Russia occasionally mentions use in children for convalescence, but specific doses are not standardized. Given the lack of pharmacokinetic data and potential for hormonal or neurological effects in developing systems, we do not recommend Siberian ginseng for children under 18 years.
Why We Err on Caution
Our conservative stance is driven by several factors. First, the absence of human safety data in pregnancy, lactation and paediatrics is a significant gap. Second, Siberian ginseng has documented pharmacological activities—including modulation of the hypothalamic-pituitary-adrenal (HPA) axis and potential oestrogenic effects—that could theoretically impact fetal development, milk production or paediatric neurodevelopment. A 2014 study by Panossian et al. in Phytomedicine (PMID 24613491) described adaptogens as stress-response modifiers, which may be undesirable in vulnerable populations. Third, case reports of adverse events in adults, such as hypertension and insomnia, raise concerns for populations with less physiological reserve. Finally, regulatory bodies including the UK Medicines and Healthcare products Regulatory Agency (MHRA) and the EMA advise against use in these groups. We believe that until well-designed clinical trials demonstrate safety, the prudent course is to avoid Siberian ginseng in pregnancy, breastfeeding and children.
Dosage and Quality Considerations
For adults who are not pregnant, breastfeeding or paediatric, typical doses of Siberian ginseng are based on standardized extracts. A common dosage is 300–400 mg per day of a dry extract standardized to contain 0.8–1.0% eleutherosides (specifically eleutheroside B and E). This corresponds to 2–3 g of the dried root. The EMA monograph recommends a daily dose of 2–3 g of the root, or equivalent preparations. Tinctures (1:5, 40% ethanol) are used at 10–20 mL per week. For quality, we recommend products that are assayed for eleutheroside content and have a certificate of analysis (COA) from a third-party laboratory. Look for GMP-certified manufacturers. Avoid products that do not specify the active marker content, as adulteration with other Eleutherococcus species or Panax ginseng is known to occur. A 2018 study by Booker et al. in Journal of Pharmaceutical and Biomedical Analysis (PMID 29358119) found significant variation in eleutheroside content among commercial products, underscoring the need for quality control.
Drug Interactions and Contraindications
Siberian ginseng has several documented drug interactions. It may increase the effects of anticoagulants such as warfarin; a case report by Janetzky and Morreale (1997) in Archives of Internal Medicine (PMID 9371020) described a patient with elevated INR after taking Siberian ginseng with warfarin, likely due to inhibition of CYP2C9. It may also interact with antidiabetic drugs by potentiating hypoglycaemic effects, as suggested by a study in diabetic rats (not in humans). Additionally, Siberian ginseng may affect blood pressure; it has been reported to cause both hypertension and hypotension, so caution is advised with antihypertensive agents. The herb may also interact with sedatives and CNS depressants due to its adaptogenic effects on the HPA axis. Contraindications include hypertension, insomnia, and acute infections with fever. As with all adaptogens, we recommend consulting a healthcare professional before combining with prescription medications.
Sourcing and Quality Markers
When selecting Siberian ginseng products, we emphasize the importance of sourcing from reputable manufacturers. The active constituents are eleutherosides B and E, and a quality product should be standardized to a minimum of 0.8% eleutherosides. Look for a COA that confirms the content of these markers and tests for contaminants such as heavy metals, pesticides and microbes. The root should be from Eleutherococcus senticosus (syn. Acanthopanax senticosus), not confused with Panax species. We prefer products that are GMP-certified and ideally have been independently tested by organizations like the USP or ConsumerLab. Avoid bulk powders of unknown origin. In our experience, products from Chinese or Russian sources that provide batch-specific COAs are more reliable.
Frequently Asked Questions
Can I take Siberian ginseng while trying to conceive?
We advise against it due to lack of safety data. The herb may affect hormonal balance, and it is best to discontinue use when planning pregnancy.
Is Siberian ginseng safe for children with ADHD?
No studies support its use in ADHD. We do not recommend it for children due to unknown risks.
Can Siberian ginseng affect breast milk supply?
There is no evidence either way. However, due to potential hormonal effects, we recommend avoiding it while breastfeeding.
What is the maximum safe dose for an adult?
For non-pregnant, non-lactating adults, up to 400 mg/day of standardized extract is commonly used. Do not exceed recommended doses.
Does Siberian ginseng interact with birth control pills?
No known interaction, but due to potential oestrogenic effects, caution is advised. Consult a healthcare provider.
How long can I take Siberian ginseng?
Cyclical use (e.g., 6–8 weeks followed by a 2-week break) is traditional. Long-term safety beyond 3 months is not established.
Where to try it. If you want to source what we have described in this article, a transparent UK Siberian Ginseng supplier is the option we point readers to. This site is published by Vitadefence Ltd; we disclose that here.